Openly accessible : Columbia Journalism Review

abernard102@gmail.com 2013-11-15

Summary:

"Last month John Bohannon, a biologist and science writer, published the kind of piece in Science magazine that defies classification. One part sting operation, one part creative investigation, the article, “Who’s Afraid of Peer Review?” chronicled Bohannon’s attempts over the course of a year to factcheck the peer review process of a number of open-access scientific journals. Bohannon’s piece is by far the most ambitious attempt to check the rigor of peer review in open-access publishing, but perhaps because of the heated charge behind the topic, press coverage of his project was out of sync with the larger conversation happening in the ivory tower. One of the most debated topics in science publishing, open-access journals don’t charge subscription fees, making it easier for the public (and universities) to access scientific literature. They’re hailed by advocates as the answer to the skyrocketing fees of the traditional journals, which is causing a 'serials crisis' in university libraries, where diminishing budgets mean that administrations can no longer afford to keep bundled publications fully stocked. But the price of publication must shift somewhere: to foundations, donations, or, in some cases, charging the scientists themselves for the right to publish. Critics complain that open-access models have led to a plethora of second-class publications skimping on peer-review costs, or, in the case of fee-charging open access journals, create financial burdens for researchers, and making an incentive for publications to accept papers of any quality. After receiving a note from a scientist in India complaining of the fee attached to publishing her latest paper, Bohannon, who regularly covers science in the developing world, conceived of an ambitious plan to test the fee-based, open-access journals’ rigor. Under the pseudonym 'Ocorrafoo Cobange,' Bohannon wrote a mock study in which he found a new anti-cancer substance, with 'wonder drug' potential, in a substance extracted from lichen. Bohannon documents the study’s many flaws in his article ... The journals didn’t reject his paper. Over half (157) the journals accepted it outright; 97 rejected it. The rest were a mix of nonexistent or abandoned publications or short-staffed ones, where the paper was still under review by the time Science published the sting. The media’s reaction to Bohannon’s project was positive and largely one note. He was hailed for his creativity in National GeographicNPRThe Scientist, and The Discovery Channel’s news site. (The Chronicle of Higher Education was a rare outlier, unpacking Bohannon’s piece, and its critical reception, more fully in its coverage.)  But in their quick-hit, laudatory coverage of the piece, reporters missed the heated criticism launched at Bohannon by the academic world.  'Bohannon’s sting has some major problems itself—most glaringly, the fact that he didn’t submit the paper to any traditional subscription journals,' wrote Michael Eisen, an associate professor of molecular and cell biology at Berkeley ..."

Link:

http://www.cjr.org/the_observatory/science_magazine_sting_john_bo.php

From feeds:

Open Access Tracking Project (OATP) » abernard102@gmail.com

Tags:

oa.new oa.gold oa.comment oa.quality oa.fees oa.credibility oa.journals

Date tagged:

11/15/2013, 11:09

Date published:

11/15/2013, 06:09